CALL US TODAY:
(305) 274-0221

Omadacycline Noninferior to Moxifloxacin in CABP Study, Linezolid in ABSSSI Study

13

  • Feb

  • 2019

images images Latest News images 0 Comments
Omadacycline Noninferior to Moxifloxacin in CABP Study, Linezolid in ABSSSI Study

Omadacycline is noninferior to moxifloxacin for community-acquired bacterial pneumonia and noninferior to linezolid for acute bacterial skin infections.

« Previous
Next »

Follow Us

  • LinkedIn
  • YouTube

Patient Portal

Pay Your Bill Online!

© 2024 Judith Crowell, MD and Associates


7800 SW 87th Avenue | Suite C-300 | Miami, Florida 33173

Designed By Emrah Interactive